verapamil has been researched along with Rheumatoid Arthritis in 2 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| " This study was carried out to examine the effect of rheumatoid arthritis (RA) on the pharmacokinetics and pharmacodynamics of verapamil." | 9.09 | Decreased dromotropic response to verapamil despite pronounced increased drug concentration in rheumatoid arthritis. ( Jamali, F; Mayo, PR; Russell, AS; Skeith, K, 2000) |
| "Active rheumatoid arthritis (RA), obesity, and old age are associated with reduced responsiveness to the calcium channel antagonist verapamil despite increased drug concentrations." | 7.75 | Influence of controlled rheumatoid arthritis on the action and disposition of verapamil: focus on infliximab. ( Ihejirika, B; Jamali, F; Lewanczuk, RZ; Ling, S; Russell, AS, 2009) |
| " This study was carried out to examine the effect of rheumatoid arthritis (RA) on the pharmacokinetics and pharmacodynamics of verapamil." | 5.09 | Decreased dromotropic response to verapamil despite pronounced increased drug concentration in rheumatoid arthritis. ( Jamali, F; Mayo, PR; Russell, AS; Skeith, K, 2000) |
| "Active rheumatoid arthritis (RA), obesity, and old age are associated with reduced responsiveness to the calcium channel antagonist verapamil despite increased drug concentrations." | 3.75 | Influence of controlled rheumatoid arthritis on the action and disposition of verapamil: focus on infliximab. ( Ihejirika, B; Jamali, F; Lewanczuk, RZ; Ling, S; Russell, AS, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ling, S | 1 |
| Lewanczuk, RZ | 1 |
| Russell, AS | 2 |
| Ihejirika, B | 1 |
| Jamali, F | 2 |
| Mayo, PR | 1 |
| Skeith, K | 1 |
1 trial available for verapamil and Rheumatoid Arthritis
| Article | Year |
|---|---|
Decreased dromotropic response to verapamil despite pronounced increased drug concentration in rheumatoid arthritis.
Topics: Adult; Area Under Curve; Arthritis, Rheumatoid; Calcium Channel Blockers; Female; Humans; Interleuki | 2000 |
1 other study available for verapamil and Rheumatoid Arthritis
| Article | Year |
|---|---|
Influence of controlled rheumatoid arthritis on the action and disposition of verapamil: focus on infliximab.
Topics: Antibodies, Monoclonal; Antirheumatic Agents; Area Under Curve; Arthritis, Rheumatoid; Biological Av | 2009 |